No Junk Plans Act

Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935), and the Primary and Behavioral Health Care Access Act (HR 5575)

Client expense: $130,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Small Business Administration (SBA), Treasury, Dept of, U.S. Postal Service (USPS)

H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935), and the Primary and Behavioral Health Care Access Act (HR 5575) Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123), Families First Coronavirus Response Act (P.L. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (HR 748) (P.L. 116-136), and HEROES Act (H.R. 6800).

Client expense: $50,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)

H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935), and the Primary and Behavioral Health Care Access Act (HR 5575) Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123), Families First Coronavirus Response Act (P.L. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (HR 748) (P.L. 116-136), and HEROES Act (H.R. 6800).

Client expense: $50,000 · Firm income: Not reported

- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage. - H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support - H.R. 6514, Worker Health Coverage Protection Act, Support - H.R. 3832, S. 1257, Legacy IRA Act, Support - H.R. 6408 - Save the Organizations that Serve America Act - S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support -RESTART Act (S. 3814), Oppose - Paycheck Protection Program Flexibility Act of 2020(S. 3833/H.R. 7010/H.R.6886) Support -Help Charities Protect Communities Act (Rep. Beatty), bill number to be determined. Support - S.Amdt. 1566 to the CARES Act,Charitable Giving Amendment.Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support.

Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care Risk adjustment Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace HR 6800, the HEROES Act H.R.1425, the Patient Protection and Affordable Care Enhancement Act (ACEA) Addressing bureaucratic hurdles to treating substance use disorder in care coordinated systems created by 42 CFR Part 2 Short-term, limited-duration insurance H.R.3630, No Suprises Act S. 1895 Lower Health Care Costs Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1556, No Junk Plans Act Lower Health Care Costs Act (S. 1895) Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) HR 1010, reversing the Administration's rule on short-term, limited-duration insurance Surprise Billing Special Enrollment Period for Marketplace Reinsurance Affordable Care Act implementation with respect to safety net health plans Network adequacy

Client expense: $70,000 · Firm income: Not reported

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935), and the Primary and Behavioral Health Care Access Act (HR 5575) Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123), Families First Coronavirus Response Act (P.L. 116-127), and Coronavirus Aid, Relief, and Economic Security (CARES) Act (HR 748) (P.L. 116-136).

Client expense: $50,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace S.1210/S.3374, Protecting Jessica Grubbs Legacy Act H.R.2062, the Overdose Prevention and Patient Safety Act Addressing bureaucratic hurdles to treating substance use disorder in care coordinated systems created by 42 CFR Part 2 Marketplace Stabilization Short-term, limited-duration insurance H.R.3630, No Suprises Act S. 1895 Lower Health Care Costs Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1556, No Junk Plans Act Lower Health Care Costs Act (S. 1895) Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) HR 1010, reversing the Administration's rule on short-term, limited-duration insurance Surprise Billing Reinsurance

Client expense: $70,000 · Firm income: Not reported

- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.

- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935), and the Primary and Behavioral Health Care Access Act (HR 5575)

Client expense: $30,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 19: Lower Costs, More Cures Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: More Efficient Tools to Realize Information for Consumers Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4698: Medical Records Access Fairness Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions Draft Legislation related to 21st Century Cures Act 2.0; all provisions Antibiotic Development Incentives discussions; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 110:Medical Expense Savings Act; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions Antibiotic Development Incentives discussions; all provisions

Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care Federally Facilitated Marketplace implementation Risk adjustment Strategies to address substance use disorders Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace S.1850, Protecting Jessica Grubbs Legacy Act The Overdose Prevention and Patient Safety Act Addressing bureaucratic hurdles to treating substance use disorder in care coordinated systems created by 42 CFR Part 2 Marketplace Stabilization Association Health Plans Short-term, limited-duration insurance No Suprises Act S. 1895 Lower Health Care Costs Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1556, No Junk Plans Act H.R.987, Strengthening Health Care and Lowering Prescription Drug Costs Act HR 1010, reversing the Administration's rule on short-term, limited-duration insurance Surprise Billing Reinsurance

Client expense: $70,000 · Firm income: Not reported

- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions

Client expense: $160,000 · Firm income: Not reported

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions

Client expense: $160,000 · Firm income: Not reported

H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions

Issues related to health insurance for children and women of childbearing age, Medicaid, special enrollment periods for pregnancy, and legislation to reform the Affordable Care Act, focusing on short-term limited duration plans, association health plans, reinsurance, among other issues. Specific legislation includes: a bill to reverse the rule on short-term limited duration insurance (H.R. 1010, S. 1556) and the Protecting Americans with Preexisting Conditions Act of 2019 (HR 986), and the Family Coverage Act (S. 1935).

Client expense: $30,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)

Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care Federally Facilitated Marketplace implementation Risk adjustment Strategies to address substance use disorders Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace S.1850, Protecting Jessica Grubbs Legacy Act The Overdose Prevention and Patient Safety Act Addressing bureaucratic hurdles to treating substance use disorder in care coordinated systems created by 42 CFR Part 2 Marketplace Stabilization Association Health Plans Short-term, limited-duration insurance No Suprises Act S. 1895 Lower Health Care Costs Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1556, No Junk Plans Act H.R.987, Strengthening Health Care and Lowering Prescription Drug Costs Act HR 1010, reversing the Administration's rule on short-term, limited-duration insurance Surprise Billing Reinsurance

Client expense: $70,000 · Firm income: Not reported

- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend PL 111-148, The Patient Protection and Affordable Care Act, to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.

Client expense: Not reported · Firm income: $40,000

Government targets: SENATE

H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions

Client expense: $340,000 · Firm income: Not reported

H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions

Client expense: $340,000 · Firm income: Not reported

Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Supported HR 2734/S 1448 - Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act Joined the Friends of NIDA in sending a letter in support of the Marijuana and Cannabidiol Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences. Provided technical assistance and support for new legislation requiring all controlled substance prescribers with a DEA license to become DATA 2000 waiver trained Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Tobacco Partners Coalition in sending a letter in response to a request for comment issued by the Food and Drug Administration. The request for comment seeks industry input regarding draft guidance being developed by the FDA on modifications to compliance policy for certain deemed tobacco products. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 would exempt some cigars, including some inexpensive, machine-made cigars, from FDA oversight. Advocated that FDA rightly concluded in the final Deeming Rule that there was no public health justification for exempting any cigars from FDA oversight because all cigars pose significant health risks. One difference this year is that the House added language specifying that cigars with flavor additives would not fit the bills definition of a premium cigar. Despite the flavors language, the bill would still exempt some cheap, machine-made cigars that youth are using from FDA oversight. The Senate bill did not include language on flavors. Supported The Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act) is legislation that would curb the use of flavors in tobacco products, including e-cigarettes and cigars. Supported introduction of legislation to make the Veterans Health Administration (VHA) facilities smoke-free. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Supported HR 2734/S 1448 - Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act Joined the Friends of NIDA in sending a letter in support of the Marijuana and Cannabidiol Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences. Provided technical assistance and support for new legislation requiring all controlled substance prescribers with a DEA license to become DATA 2000 waiver trained Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Tobacco Partners Coalition in sending a letter in response to a request for comment issued by the Food and Drug Administration. The request for comment seeks industry input regarding draft guidance being developed by the FDA on modifications to compliance policy for certain deemed tobacco products. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 would exempt some cigars, including some inexpensive, machine-made cigars, from FDA oversight. Advocated that FDA rightly concluded in the final Deeming Rule that there was no public health justification for exempting any cigars from FDA oversight because all cigars pose significant health risks. One difference this year is that the House added language specifying that cigars with flavor additives would not fit the bills definition of a premium cigar. Despite the flavors language, the bill would still exempt some cheap, machine-made cigars that youth are using from FDA oversight. The Senate bill did not include language on flavors. Supported The Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act) is legislation that would curb the use of flavors in tobacco products, including e-cigarettes and cigars. Supported introduction of legislation to make the Veterans Health Administration (VHA) facilities smoke-free. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Supported HR 2734/S 1448 - Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act Joined the Friends of NIDA in sending a letter in support of the Marijuana and Cannabidiol Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences. Provided technical assistance and support for new legislation requiring all controlled substance prescribers with a DEA license to become DATA 2000 waiver trained Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Tobacco Partners Coalition in sending a letter in response to a request for comment issued by the Food and Drug Administration. The request for comment seeks industry input regarding draft guidance being developed by the FDA on modifications to compliance policy for certain deemed tobacco products. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 would exempt some cigars, including some inexpensive, machine-made cigars, from FDA oversight. Advocated that FDA rightly concluded in the final Deeming Rule that there was no public health justification for exempting any cigars from FDA oversight because all cigars pose significant health risks. One difference this year is that the House added language specifying that cigars with flavor additives would not fit the bills definition of a premium cigar. Despite the flavors language, the bill would still exempt some cheap, machine-made cigars that youth are using from FDA oversight. The Senate bill did not include language on flavors. Supported The Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act) is legislation that would curb the use of flavors in tobacco products, including e-cigarettes and cigars. Supported introduction of legislation to make the Veterans Health Administration (VHA) facilities smoke-free. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Supported HR 2734/S 1448 - Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act Joined the Friends of NIDA in sending a letter in support of the Marijuana and Cannabidiol Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences. Provided technical assistance and support for new legislation requiring all controlled substance prescribers with a DEA license to become DATA 2000 waiver trained Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Tobacco Partners Coalition in sending a letter in response to a request for comment issued by the Food and Drug Administration. The request for comment seeks industry input regarding draft guidance being developed by the FDA on modifications to compliance policy for certain deemed tobacco products. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 would exempt some cigars, including some inexpensive, machine-made cigars, from FDA oversight. Advocated that FDA rightly concluded in the final Deeming Rule that there was no public health justification for exempting any cigars from FDA oversight because all cigars pose significant health risks. One difference this year is that the House added language specifying that cigars with flavor additives would not fit the bills definition of a premium cigar. Despite the flavors language, the bill would still exempt some cheap, machine-made cigars that youth are using from FDA oversight. The Senate bill did not include language on flavors. Supported The Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act) is legislation that would curb the use of flavors in tobacco products, including e-cigarettes and cigars. Supported introduction of legislation to make the Veterans Health Administration (VHA) facilities smoke-free. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 2874 and S 1576 - Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central online portal so that people can access all information as a one-stop shop, and submit complaints and violations. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. Joined members of the Mental Health Liaison Group (MHLG) and 25 other organizations in sending letters expressing support for the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Supported HR 2734/S 1448 - Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. Joined other organizations in sending a letter urging Members of Congress to support the Johns S. McCain Opioid Addiction Prevention Act (S. 724 / H.R. 1614). The legislation would limit initial opioid prescriptions for acute pain to 7 days. Supported S 1556 - No Junk Plans Act. This bill would legislatively block implementation of the Trump Administrations Short-Term, Limited Duration Insurance rule. This rule loosened restrictions on these plans, allowing enrollees to be on short-term plans for up to a year and renew their short-term plan for up to 3 years. Joined members of the Partnership to Amend 42 CFR Part 2 in sending a letter urging addition of the legislative language in S. 1012, the Protecting Jessica Grubbs Legacy Act to the Lower Health Care Costs Act of 2019. S. 1012 would align Part 2 with HIPAA for TPO, and strengthen protections against the use of addiction records in criminal, civil, or administrative proceedings. In addition, the bill further amplifies patient protections by incorporating antidiscrimination language, significantly enhancing penalties for any breach of a persons substance use record, and adding breach notification requirements. Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients. Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act Joined the Friends of NIDA in sending a letter in support of the Marijuana and Cannabidiol Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences. Provided technical assistance and support for new legislation requiring all controlled substance prescribers with a DEA license to become DATA 2000 waiver trained Joined over 75 organizations in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763), which would increase the number of residency positions funded by Medicare in hospitals around the country by 15,000 over 5 years. This legislation would work to expand the physician workforce to address alarming projected deficits of physicians in both primary and specialty care. Joined members of the Mental Health Liaison Group (MHLG) in sending a letter to the leadership of the House Committee on Budget in support of H.R. 2021 - the Investing for the People Act of 2019. This legislation would raise both the defense and nondefense discretionary caps by $88 billion each in Fiscal Years 2020 and 2021. Joined members of the Tobacco Partners Coalition in sending a letter in response to a request for comment issued by the Food and Drug Administration. The request for comment seeks industry input regarding draft guidance being developed by the FDA on modifications to compliance policy for certain deemed tobacco products. Joined members of the Mental Health Liason Group (MHLG) in sending a letter voicing support for H.R. 1329, the Medicaid Reentry Act. The bill would work to grant Medicaid eligibility to incarcerated individuals 30-days prior to their release. The Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 would exempt some cigars, including some inexpensive, machine-made cigars, from FDA oversight. Advocated that FDA rightly concluded in the final Deeming Rule that there was no public health justification for exempting any cigars from FDA oversight because all cigars pose significant health risks. One difference this year is that the House added language specifying that cigars with flavor additives would not fit the bills definition of a premium cigar. Despite the flavors language, the bill would still exempt some cheap, machine-made cigars that youth are using from FDA oversight. The Senate bill did not include language on flavors. Supported The Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act) is legislation that would curb the use of flavors in tobacco products, including e-cigarettes and cigars. Supported introduction of legislation to make the Veterans Health Administration (VHA) facilities smoke-free. Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements Provided technical assistance regarding Senator Shaheen's Turn the Tide Act which would increase funding to combat the addiction crisis, including efforts to stregthenen the addiction treatment workforce and increase Medicaid reimbursement for addiction treatment providers

- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage

H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality H.R.2115 Public Disclosure of Drug Discounts Act - legislation to provide greater transparency of discounts provided by drug manufacturers. S.340/H.R.965 CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1520, the Purple Book Continuity Act of 2019; publication of a list of licensed biological products H.R. 1503, the Orange Book Transparency Act of 2019; list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, H.R. 1781 Payment Commission Data Act of 2019 - provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information H.R. 1264 Payment Commission Data Act of 2019 - provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, H.R.2296, S.1391 FAIR Drug Pricing Act - Rx pricing transparency, require manufacturers to justify price increases H.R.2376, S.1227 Prescription Pricing for the People Act - directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain S.Res.134 - A resolution expressing the sense of the Senate that the Department of Justice should reverse its position in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.) H.R.1010 - To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect H.Res.356 - Expressing support for Designation of May as "National Asthma and Allergy Awareness Month" H.R.1868 - Health Care Affordability Act of 2019 - reducing insurance premiums and out-of-pocket costs in the individual and small group markets, both for low-income families and those that are not eligible for tax credits H.R.1385 State Allowance for a Variety of Exchanges (SAVE) Act - preserve the option of States to implement health care marketplaces H.R.1386 ENROLL Act - amending ACA with new Navigator program requirements H.R.1425 State Health Care Premium Reduction Act - Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market S.1213 Consumer Health Insurance Protection Act - - comprehensive insurance reform proposals including provisions pegging consumer assistance to plans with higher actuarial value, lowering out-of-pocket maximums, extending eligibility for subsidies, fixing family glitch, investing in enrollment outreach, requiring insurers to cover emergency services at in-network costs, making short-term limited duration plans subject to ACAs consumer protections H.R.986 - Protecting Americans with Preexisting Conditions Act of 2019 - certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect H.R.2569, S.1365 Comprehensive Addiction Resources Emergency Act of 2019 - provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Ac- requires the Department of Health and Human Services (HHS) to conduct outreach and educational activities regarding federally-facilitated exchanges (i.e., health insurance exchanges that are established and operated within states by HHS). The activities must inform potential enrollees of the availability of coverage and related financial assistance under the exchanges and must be provided in culturally and linguistically appropriate formats. S.1556 No Junk Plans Act - rule entitled Short-Term, Limited Duration Insurance shall have no force or effect. S.1531 STOP Surprise Medical Bills Act - provide protections for health insurance consumers from surprise billing H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information No Surprises Act - legislation to protect consumers from surprise medical bills Protecting People From Surprise Medical Bills Act - legislation to protect consumers from surprise medical bills, arbitration as payment mechanism H.R.2075,S.1013 School-Based Health Center Reauthorization Act - reauthorize school-based health centers S.1737 Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits H.R.748, S. 684 Middle Class Health Benefits Tax Repeal Act of 2019 - repeal the excise tax on high value employer-sponsored health care coverage, also known as the Cadillac Tax S.1935 Family Coverage Act - fix ACAs family glitch S. 1801 Affordable Medications Act - increase drug price transparency and affordability, spur innovation, and enhance competition S.455/ H.R.987 - MORE Health Education Act - funding for Federal Exchange outreach and educational activities H.R.3180, S. 1770 RISE (Resilience Investment, Support, and Expansion) from Trauma Act - improve the identification and support of children and families who experience trauma Draft legislation on patent evergreening Legislation to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)